Onyx Axiom

Onyx Axiom is an early-stage biotechnology company focused on the discovery and development of novel small molecule therapeutics for oncology and autoimmune disorders. The company utilizes its proprietary Axiom Discovery Platform to identify and optimize drug candidates against high-value, previously undruggable targets. By integrating advanced computational modeling with high-throughput screening, Onyx Axiom aims to accelerate the transition from target identification to clinical evaluation. The firm is currently advancing a pipeline of internal programs while exploring strategic collaborations to expand the reach of its technology.